Making Best Practice, Every Day Practice
This resource is fully searchable using the search box at the top of the page, or to narrow down your selection using filters click on 'Knowledge hub' in the main navigation.
More than 4.9 million people in the UK have diagnosed diabetes and by 2030 Diabetes UK estimate there will be 5.5 million people with diabetes.
The care of patients with diabetes – particularly type 2 diabetes which counts for about 90% of patients seen in primary care – is a significant challenge.
Our resources focus on:
Detection of pre-diabetes conditions frequently associated with obesity and metabolic disorders
Early diagnosis of type 2 diabetes
Interventions to reduce the risks of cardiovascular and renal disease (the cardio-renal syndrome)
Glycaemic control with established therapies including metformin
The roles for newer agents including SGLT2 inhibitors and DDP-4 inhibitors
Importance of lipid (cholesterol) management and antihypertensive therapy
Additional contributions discuss:
The initiation and intensification of insulin in people with type 2 diabetes
Diagnosis and management of people with type 1 diabetes
Prevention of hypoglycaemia
Patients with chronic conditions such as heart disease or diabetes need to plan carefully before travelling long distances and taking holidays. Lifestyle changes can have an important impact on disease control, but a bit of thought and preparation beforehand should ensure that your patients’ holidays are both happy and healthy.
People with diabetes used to be advised to watch their carbohydrate – particularly sugar – intake. But dietary recommendations have developed over the past few years so that they are now similar to the healthy diet that we should all be eating. Are there any remaining differences in what we should be telling patients with diabetes about their diet? Fewer than you might think. In this article we take a ‘supermarket tour’ that explains what patients with diabetes should be putting in their trolleys and what they should be leaving on the shelves.
The number of people with diabetes in the UK is almost 1.8 million and this is continuing to rise, according to recent figures. But only about half of these are currently diagnosed. It is obviously essential to ensure that these people are diagnosed as early as possible and then managed appropriately to ensure they receive the best possible care to minimise long-term complications. In this article, we review how to diagnose diabetes accurately, based on good practice recommended in standard two of the National Service Framework (NSF) for Diabetes. What should we be measuring in people who present with the classic symptoms and in those who do not to ensure an accurate diagnosis of diabetes?
For people with long-term conditions, self-care can have as much, if not more, influence on their health than prescribed medication and treatment. Yet, in many cases, healthcare professionals become frustrated when attempts to improve peoples’ self-care behaviours prove unsuccessful. This article looks at some of the reasons why it can be difficult to encourage people with diabetes or cardiovascular disease to look after themselves effectively; what types of practice can help us to increase people’s success in managing long-term conditions; and how we can incorporate empowering techniques in our day-to-day consultations.
Patients with diabetes are at high risk of cardiovascular disease and aspirin is an important part of prevention strategies. Although it is effective and relatively well-tolerated, studies have shown that many patients with diabetes are not taking aspirin. In this article, we review why aspirin should be considered in patients with diabetes, the benefits it might achieve and areas where caution is required.
Type 2 diabetes and the metabolic syndrome (where a patient has a cluster of metabolic risk factors, including atherogenic dyslipidaemia, raised blood pressure and insulin resistance) are growing problems. Most researchers believe that the key is central obesity – fat stored in the abdomen around internal organs, which produces inflammatory mediators such as tumour necrosis factor (TNF). This leads to insulin resistance, when the normal amount of insulin secreted by the pancreas is no longer able to activate receptors on body cells, resulting in impaired glucose metabolism. However, this is an evolving science and the precise details are not yet fully understood. The insulin resistance/metabolic syndrome often leads to type 2 diabetes as the pancreas becomes less responsive, but this is not inevitable.
Renal disease is common and is increasing in prevalence as the main risk factor for impaired kidney function – diabetes – affects more people. Approximately 30% of patients with type 2 diabetes develop some degree of nephropathy, with some ethnic groups at even higher risk. Diabetes is now the largest single cause of end-stage renal disease in the UK, accounting for 30–40% of all cases. The very early stages are asymptomatic and the disease process develops slowly over 15–20 years, so early screening and prevention strategies are paramount in reducing the burden of renal failure. Primary care nurses are well placed to play a pivotal role in this process.
There is good evidence that tight glycaemic control significantly improves outcomes in patients with type 2 diabetes. All practice nurses will be looking to achieve the new General Medical Services contract (GMS2) targets for HbA1c reduction in diabetes (see box). Practices will be developing prescribing strategies to achieve this reduction, in accordance with good clinical practice. Metformin offers an important first-line therapy for type 2 diabetes. The introduction of a new, sustained-release formulation – Glucophage SR – should improve patient compliance with metformin and so improve glycaemic control.
More and more is being expected of practices in improving the management of diabetes – with initiatives such as the National Service Framework (NSF) for Diabetes and NICE guidance setting increasingly ambitious targets. The National Diabetes Support Team (NDST) has been set up to help support local services throughout the NHS and in meeting these challenges. In this issue, they share latest advice for practices and patients on disposing of used syringes and other sharps.
Primary care nurses play a central role in the management of type 2 diabetes in the community. This includes helping patients to use their drug treatment correctly. Although many patients with type 2 diabetes initially respond well to weight loss and exercise, most require oral hypoglycaemics and half of all patients eventually require insulin to control their glucose levels in order to prevent the devastating long-term complications of inadequately controlled diabetes. Linda Goldie gives an up-to-date review of the newer insulins – including the insulin analogues, insulin lispro, insulin aspart and insulin glargine – that have been introduced.
A unique new e-platform for primary care
By continuing to this site you are confirming that you are a healthcare professional and are opting into the use of cookies.
